Blog

Oct 16, 2024, 13:23

Tackling global health inequities in lung cancer – EGFR Positive Lung Cancer UK

EGFR Positive Lung Cancer UK posted the following on X:

“Lung cancer is challenging enough – imagine facing it without access to essential tests or treatments. For many EGFR+ patients worldwide, this is reality. Tackling global health inequities means making diagnostics and targeted therapies accessible to all.”

Exploring EGFR Mutations in Resected Stage I-III NSCLC in Low- and Middle-Income Countries: Bridging the Gap in Global Cancer Care

Authors: Enrique Caballé-Perez, Luis Cabrera-Miranda, Oscar Arrieta.

Tackling global health inequities in lung cancer - EGFR Positive Lung Cancer UK

cancer Cancer research Diagnostics EGFR Mutations EGFR Positive Lung Cancer UK Enrique Caballé-Pérez global health inequities Healthcare Access low- and middle-income countries Luis Cabrera-Miranda Lung cancer NSCLC OncoDaily Oncology Oscar Arrieta patient care targeted therapies

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Giuliana Rancic and Breast Cancer: How She Went Against, How She Survived, and More

Vincent Rajkumar: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma

"The Doctor Who Always Has Candies in His Pocket": A Conversation with Professor Guangchao Zhang, Pioneer of Pediatric Surgical Oncology in China

Special Coverage